WAM
TMO icon

Wolverine Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Wolverine Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$852K Sell
1,700
-1,800
-51% -$864K 0.01% 835
2026
Q1 		$1.72M Sell
3,500
-400
-10% -$217K 0.02% 611
2025
Q4 		$2.26M Buy
3,900
+1,000
+34% +$566K 0.02% 567
2025
Q3 		$1.41M Sell
2,900
-2,700
-48% -$1.26M 0.01% 656
2025
Q2 		$2.27M Buy
5,600
+3,600
+180% +$1.51M 0.02% 493
2025
Q1 		$995K Sell
2,000
-7,200
-78% -$3.9M 0.01% 688
2024
Q4 		$4.79M Sell
9,200
-1,500
-14% -$825K 0.05% 330
2024
Q3 		$6.62M Sell
10,700
-12,200
-53% -$7.22M 0.07% 256
2024
Q2 		$12.7M Buy
22,900
+2,400
+12% +$1.37M 0.14% 160
2024
Q1 		$11.9M Sell
20,500
-15,100
-42% -$8.47M 0.14% 162
2023
Q4 		$18.9M Buy
35,600
+10,800
+44% +$5.23M 0.16% 157
2023
Q3 		$12.6M Buy
24,800
+2,700
+12% +$1.44M 0.14% 169
2023
Q2 		$11.5M Sell
22,100
-51,000
-70% -$27.5M 0.14% 163
2023
Q1 		$42.1M Buy
73,100
+23,600
+48% +$13.3M 0.5% 45
2022
Q4 		$27.3M Buy
49,500
+44,000
+800% +$23.3M 0.28% 98
2022
Q3 		$2.79M Buy
+5,500
New +$3.08M 0.03% 470
2016
Q1 		– Sell
-147
Closed -$61K – 1614
2015
Q4 		$61K Hold
147
– – ﹤0.01% 1101
2015
Q3 		$16K Hold
147
– – ﹤0.01% 1502
2015
Q2 		$53K Buy
147
+47
+47% +$6.13K ﹤0.01% 1289
2015
Q1 		$42K Sell
100
-481
-83% -$62K ﹤0.01% 1292
2014
Q4 		$128K Sell
581
-194
-25% -$23.6K ﹤0.01% 1102
2014
Q3 		$160K Sell
775
-13
-2% -$1.58K ﹤0.01% 1149
2014
Q2 		$182K Buy
788
+502
+176% +$59.1K ﹤0.01% 966
2014
Q1 		$82K Buy
286
+235
+461% +$27.9K ﹤0.01% 1187
2013
Q4 		$124K Sell
51
-56
-52% -$5.57K ﹤0.01% 1363
2013
Q3 		$101K Sell
107
-25
-19% -$2.26K ﹤0.01% 1454
2013
Q2 		$62K Buy
+132
New +$11K ﹤0.01% 1612

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wolverine Asset Management's TMO Position: Q2 2026 in Review

Wolverine Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 77% in Q2 2026, selling an estimated $305K and leaving 188 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Wolverine Asset Management first reported a position in TMO in Q1 2014 and has held it in 19 quarters since. The position peaked at $10.5M in Q2 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wolverine Asset Management held 188 shares of Thermo Fisher Scientific worth $94.3K as of Q2 2026.
  • Wolverine Asset Management sold 635 Thermo Fisher Scientific shares in Q2 2026, an estimated $305K.
  • Thermo Fisher Scientific made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1176 holding.
  • Wolverine Asset Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 19 quarters since.
  • Wolverine Asset Management's Thermo Fisher Scientific position peaked at $10.5M in Q2 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.